Immuno-nanoparticles hold great promise for targeted delivery of drugs, therapeutics, and diagnostics as numerous possible target receptors have been identified on the surface of cells in pathological conditions.[1–4] Under in vivo conditions, immuno-nanoparticles can deliver these agents to specific sites by both passive targeting, where a hydrophilic polymer outer layer such as polyethylene glycol (PEG) leads to longer circulation in the blood ...
[Barnard, Anna; Posocco, Paola; Pricl, Sabrina; Calderon, Marcelo; Haag, Rainer; Hwang, Mark E.; Shum, Victor W. T.; Pack, Daniel W.; Smith, David K. Journal of the American Chemical Society, 2011 , vol. 133, # 50 p. 20288 - 20300]
